Study and continuing education

Genetics University is built to work with other institutions rather than alongside them. Universities, academic medical centres and research institutes worldwide can establish specialised curricula in medical genetics and genome science together with us and offer them under their own academic roof. We bring the didactic structure, clinical case material and methodological depth; the examination order, the degree title and the academic credit remain with the partner institution.

Every collaboration begins with an assessment of need: which methods are actually in use, where the competence gaps sit, and which assessment and credit rules apply. From that we build a programme that fits the partner's curriculum rather than a finished package laid over it. We distinguish between baseline competence that must be taught institution-wide and specialist competence tailored to individual research groups or clinical divisions.

Modules are sequenced so that clinicians and researchers in active practice can complete them alongside their daily work. Each module closes with a practical assessment tied to the host's diagnostic or research environment, and every cohort receives supervised case review with experienced geneticists drawn from our network.

The programmes are modular and credit-bearing: a partner may adopt an entire twelve-week track or integrate individual modules into an existing master's programme, a continuing-education regulation, or a doctoral training group. We supply learning objectives, examination material, reference datasets and a teaching manual; the instructor may come from the host institution, with co-teaching arrangements available.

Mentorship is a structural part of every partnership, not an add-on. Early-career groups receive sustained support on study design, methodological reproducibility, ethical framing and publication strategy — across the life of a project, not as a single lecture. On request, mentorship is coupled to a joint publication or to a clinical validation study, so that the training culminates in a concrete scientific result.

Data protection, governance and intellectual property are settled in writing before the first teaching session. Research data from joint projects stays at the site of collection; we provide analysis pipelines, versioning and, on request, joint evaluation — without sensitive data ever leaving the institution.

Quality assurance is built into the lifetime of every partnership. We operate with documented learning objectives, calibrated assessment material, and an annual outcomes review that measures competence gain, completion rates and — for clinical formats — downstream impact on diagnostic workflows. Results feed back into the next cohort, so a programme need not stay identical across years but matures with both the methods and the participants.

A partnership does not end with the final module. Graduates gain access to our ongoing methodology briefings, updated reference datasets and a network of peer specialist groups that outlasts any single cohort. Where a host wishes to build a recurring programme, we lead the first cohort and progressively transfer delivery to a local teaching team — so that competence resides in the institution once the scaffolding is in place.

The curricular emphasis follows no fixed catalogue but the scientific and clinical priorities of each partner: variant interpretation and NGS pipelines, epigenetic mechanisms, multi-omics integration, clinical proteomics, rare disease genomics, oncogenomics, pharmacogenomic counselling, or population genomics attentive to local ancestry diversity. Each programme is a kit from which the relevant building blocks are selected together and fitted into the existing examination and continuing-education framework — not a finished catalogue to which the host must adapt.

Established partnerships are published only once confirmed by both parties. Enquiries are received in confidence.